White paper

Buyer's guide: Choosing an informatics platform for gene therapy R&D

Gene therapy marks a new era of medicine, bringing with it a new R&D paradigm where the product is a complex combination of genetic materials and viral or non-viral delivery vectors. As a result, conventional lab informatics platforms are not always optimal for gene therapy R&D. To help gene therapy R&D teams find an informatics platform that will efficiently advance their unique pipeline, we’ve created an evaluation framework for choosing a solution that supports modern science.
In this white paper, we discuss:
  • The complexities faced in gene therapy R&D

  • Key capabilities that have enabled our gene therapy customers to accelerate their R&D activities

  • Features to look for when assessing a platform

Companies using Benchling

View white paper

Join over 200,000 scientists using Benchling to power their biotech R&D

Helix Image